Definition and classification of generic drugs across the world R Alfonso-Cristancho, T Andia, T Barbosa, JH Watanabe Applied health economics and health policy 13, 5-11, 2015 | 96 | 2015 |
Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case SI Prada, VE Soto, TS Andia, CP Vaca, ÁA Morales, SR Márquez, ... Cost Effectiveness and Resource Allocation 16, 1-8, 2018 | 47 | 2018 |
Is the judicialization of health care bad for equity? A scoping review TS Andia, E Lamprea International Journal for Equity in Health 18 (1), 1-12, 2019 | 32 | 2019 |
Making knowledge legitimate: transnational advocacy networks' campaigns against tobacco, infant formula and pharmaceuticals T Andia, N Chorev Global Networks 17 (2), 255-280, 2017 | 22 | 2017 |
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries CE Durán, M Cañás, MA Urtasun, M Elseviers, T Andia, ... Revista Panamericana de Salud Pública 45, e10, 2021 | 19 | 2021 |
The invisible threat: trade, intellectual property, and pharmaceutical regulations in Colombia T Andia Intellectual Property, Pharmaceuticals, and Public Health: Access to Drugs …, 2011 | 15 | 2011 |
First evaluation of Colombian’s external reference pricing system T Andia, A Gaviria, C Gomez, LF Jaramillo, S Marquez, I Rodríguez, ... Value in Health 17 (3), A15, 2014 | 13 | 2014 |
Inequalities and social resilience in times of COVID-19 T Andia, N Chorev Revista de Estudios Sociales, 2-13, 2021 | 11 | 2021 |
La arquitectura institucional del Sistema de Salud Colombiano: una mirada a la ley 100 y normas posteriores T Andia, JM Gonzalez La salud en Colombia: logros, retos y recomendaciones, 209-258, 2012 | 11 | 2012 |
El “efecto portafolio” de la regulación de precios de medicamentos: La respuesta de la industria farmacéutica a la regulación de precios de medicamentos en colombia” T Andia Washington, DC https://doi. org/10.18235/0001305, 2018 | 10 | 2018 |
The inverse boomerang pattern: the Global Kaletra Campaign and access to antiretroviral drugs in Colombia and Ecuador T Andia Studies in Comparative International Development 50, 203-227, 2015 | 8 | 2015 |
Critical reflections on the Municipal Epidemiological Resilience Index used for public policy decision-making regarding the control of the COVID-19 pandemic in Colombia J Eslava-Schmalbach, A Restrepo-Henao, C Guarnizo-Herreño, ... Revista de la Facultad de Medicina 69 (2), 2021 | 7 | 2021 |
El “efecto portafolio” de la regulación de precios de medicamentos T Andia Nota técnica 44, 2018 | 7 | 2018 |
Tutelas en Salud y paradoja de los Medicamentos de Marca versus los Medicamentos Genéricos en Colombia T Andia Vitae 20 (2), 93-94, 2013 | 7 | 2013 |
Pharmaceutical Intellectual Property Rights Protection and Access to Medicines in Ecuador–State Sovereignty and Transnational Advocacy Networks T Andia Balancing Wealth and Health–The Battle for Intellectual Property and Access …, 2014 | 6 | 2014 |
Extracting low-cost signals of quality control in community pharmacies: a simulated client study in Bogotá T Andia, C Mantilla, A Morales, S Ortiz, P Rodríguez Universidad del Rosario Documentos de Trabajo, 2020 | 5 | 2020 |
Does price-cap regulation work for increasing access to contraceptives? Aggregate-and pharmacy-level evidence from Colombia T Andia, C Mantilla, A Morales, S Ortiz, P Rodríguez-Lesmes Social Science & Medicine 311, 115312, 2022 | 4 | 2022 |
Ocupaciones laborales: Clasificaciones, taxonomías y ontologías para los mercados laborales del siglo XXI C Ospino Nota técnica, IDB-TN-1513. Banco Inter-Americano de Desarrollo, 2018 | 4 | 2018 |
Protección de los derechos de propiedad intelectual farmacéuticos y acceso a los medicamentos en Ecuador: soberanía estatal y redes trasnacionales de activistas T Andia DREYFUSS, ROCHELLE C. y RODRÍGUEZ GARAVITO, CÉSAR. Entre la salud y las …, 2015 | 4 | 2015 |
Relación entre las medidas para mitigar la propagación del Covid-19 y los patrones de actividad laboral y salud mental en Colombia T Andia, L Criado, C Mantilla, A Molano, PR Lesmes y desafíos en la economía colombiana, 193, 2022 | 2 | 2022 |